The nose–brain axis as a neuroimmune conduit: how allergic rhinitis rewires the central nervous system
- 1Department of Otolaryngology-Head and Neck Surgery, The Second Hospital of Shanxi Medical University , , ,
Abstract
Allergic rhinitis (AR) has traditionally been regarded as a type I hypersensitivity disorder confined to the nasal mucosa. However, persistent symptoms, nasal hyperresponsiveness, and comorbid neuropsychiatric disturbances—including headache, fatigue, cognitive impairment (“brain fog”), anxiety, and depression—cannot be fully explained by peripheral inflammation alone, thereby implicating the involvement of central sensitization. The nose-brain axis serves as a critical bidirectional conduit that relays peripheral inflammatory signals to the central nervous system (CNS) and initiates neuroimmune crosstalk, which is now recognized as a core driver of central sensitization in AR. In this review, we systematically delineate the hierarchical mechanisms by which the nose-brain axis mediates central sensitization in AR, encompassing: peripheral neuroimmune synapse formation, trigeminal afferent signaling, central integration within the brainstem and thalamus, functional remodeling of limbic and sensory cortical regions, microglial and astrocytic activation, central cytokine network dysregulation, glutamatergic hyperexcitation, and descending modulatory imbalance. We further summarize emerging therapeutic strategies targeting the nose-brain axis, including peripheral nerve modulation, suppression of central neuroinflammation, restoration of neurotransmitter homeostasis, and psychobehavioral interventions. This review provides a unified mechanistic framework for understanding neuroinflammation and central sensitization in AR and offers novel insights for developing targeted therapies for patients with refractory AR and central comorbidities.
Related
- Environmental Ligands of the Aryl Hydrocarbon Receptor in Allergic Rhinitis: Immune and Neuroimmune Mechanisms
- Improving allergic rhinitis symptoms through nutrition as an adjunct: a systematic review and meta-analysis on the efficacy of dietary supplements
- Association of Score for Allergic Rhinitis with Serum Total IgE and Clinical Characteristics in Patients with Allergic Rhinitis
- Low-density neutrophil subsets in allergic rhinitis: heterogeneity and an emerging hypothesis for the non-type 2 endotype
- Evidence-to-Recommendation Framework for 2026 ACE Clinical Guideline on allergic rhinitis — diagnosis and management
BibTeX
@article{han2026nosebrain,
title = {{The nose–brain axis as a neuroimmune conduit: how allergic rhinitis rewires the central nervous system}},
author = {Zhuoqin Han and Fengli Cheng and Yanjie Wang and Haoxiang Zhang and Luyao Wang and Changqing Zhao},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1920083},
url = {https://europepmc.org/article/PMC/PMC13673333},
note = {CC BY},
}
RIS
TY - JOUR
TI - The nose–brain axis as a neuroimmune conduit: how allergic rhinitis rewires the central nervous system
AU - Zhuoqin Han
AU - Fengli Cheng
AU - Yanjie Wang
AU - Haoxiang Zhang
AU - Luyao Wang
AU - Changqing Zhao
PY - 2026
DA - 2026/10/02
JO - Frontiers in immunology
DO - 10.3389/fimmu.2026.1920083
UR - https://europepmc.org/article/PMC/PMC13673333
AB - Allergic rhinitis (AR) has traditionally been regarded as a type I hypersensitivity disorder confined to the nasal mucosa. However, persistent symptoms, nasal hyperresponsiveness, and comorbid neuropsychiatric disturbances—including headache, fatigue, cognitive impairment (“brain fog”), anxiety, and depression—cannot be fully explained by peripheral inflammation alone, thereby implicating the involvement of central sensitization. The nose-brain axis serves as a critical bidirectional conduit that relays peripheral inflammatory signals to the central nervous system (CNS) and initiates neuroimmune crosstalk, which is now recognized as a core driver of central sensitization in AR. In this review, we systematically delineate the hierarchical mechanisms by which the nose-brain axis mediates central sensitization in AR, encompassing: peripheral neuroimmune synapse formation, trigeminal afferent signaling, central integration within the brainstem and thalamus, functional remodeling of limbic and sensory cortical regions, microglial and astrocytic activation, central cytokine network dysregulation, glutamatergic hyperexcitation, and descending modulatory imbalance. We further summarize emerging therapeutic strategies targeting the nose-brain axis, including peripheral nerve modulation, suppression of central neuroinflammation, restoration of neurotransmitter homeostasis, and psychobehavioral interventions. This review provides a unified mechanistic framework for understanding neuroinflammation and central sensitization in AR and offers novel insights for developing targeted therapies for patients with refractory AR and central comorbidities.
SN - 1664-3224
ER -